Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

281 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A

NCT04565236

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Beijing Children's Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • The Children's Hospital Zhejiang University School of Med Hangzhou, Hangzhou Province, China
  • Shijiazhuang General Hospital Shijiazhuang, Hebei, China
  • NJ Drum Tower Hospital, the Affil Hos of NJ Univ Med School Nanjing, Jiangsu, China
View Trial Details
Completed

Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301)

NCT03370913

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • Los Angeles Orthopedic Hospital, Orthopedic Hemophilia Treatment Center Los Angeles, California, United States
  • UC Davis Hemophilia Treatment Center Sacramento, California, United States
  • University of California San Diego, Hematology and Oncology, Hemophilia &Thrombosis Treatment Center San Diego, California, United States
  • UCSF Medical Center San Francisco, California, United States
View all 49 locations
View Trial Details
Completed

ADYNOVATE Drug Use-Results Survey

NCT03169972

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Nagoya City, Japan Nagoya, Aichi-ken, Japan
  • Hirosaki City Hirosaki, Aomori, Japan
  • Chiba-City, Japan Chiba, Japan
  • Matsudo City, Japan Matsudo, Chiba, Japan
View all 52 locations
View Trial Details
Completed

Factor IX as Adjunctive Therapy to Emicizumab (EMIX)

NCT05281718

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Tulane University Lakeside Hospital and Clinics Metairie, Louisiana, United States
  • University Medical Center New Orleans New Orleans, Louisiana, United States
View Trial Details
Completed

A Gene Transfer Study for Hemophilia A

NCT03003533

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • University of California Davis - Hemostasis and Thrombosis Center Sacramento, California, United States
  • University of Florida Health Gainesville, Florida, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Mississippi Center for Advanced Medicine Madison, Mississippi, United States
View all 16 locations
View Trial Details
Completed

Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products

NCT02976753

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Swedish Orphan Biovitrum Research site Innsbruck, Austria
  • Swedish Orphan Biovitrum Research site Linz, Austria
  • Swedish Orphan Biovitrum Research Site Sankt Pölten, Austria
  • Swedish Orphan Biovitrum Research site Vienna, Austria
View all 36 locations
View Trial Details

Related conditions